Universal Biosensors Secures US FDA Approval for Coagulation Analyzer Device; Shares Surge 78%
Universal Biosensors Secures US FDA Approval for Coagulation Analyzer Device; Shares Surge 78%
环球生物传感器获得美国食品药品管理局对凝血分析仪设备的批准；股价飙升78％
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间